ZFIN Image: Xiong et al., 2021, Fig. 1

Image

Figure Caption

Fig. 1

Metabolomic assay indicated aberrant glutamine metabolism in patients with NKTCL.

(a) Distinguished serum metabolites of NKTCL (red dots), PTCL (dark blue dots), and DLBCL (light blue dots), comparing with healthy volunteer, were overlaid on human metabolic reference map (KEGG: hsa01100) using Interactive Pathways Explorer v3 (iPath 3). Pathways involving amino acid metabolism (yellow lines), nucleotide metabolism (red lines), carbohydrate metabolism (purple lines) and lipid metabolism (green lines) were highlighted.

(b) Distinguished serum metabolites of NKTCL, PTCL and DLBCL, comparing with healthy volunteer, were categorized into 4 subtypes according to their relevance to amino acid, nucleotide, carbohydrate, or lipid metabolism.

(c) KEGG metabolic pathway enrichment by ConsensusPathDB using distinguished serum metabolites of NKTCL, comparing with healthy volunteer.

(d) Standard amino acids significantly altered in NKTCL, comparing with healthy volunteer.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ EBioMedicine